Remission Duration in Acute Nonlymphocytic Leukemia: Practical and Theoretical Considerations
- 1 January 1984
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ph1-positive acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1984
- Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases.Journal of Clinical Oncology, 1983
- Chemotherapy for acute myelogenous leukemia in children and adults: VAPA updateBlood, 1983
- Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failureBritish Journal of Haematology, 1983
- The treatment of acute myelocytic leukemia in patients 30 years of age and youngerAmerican Journal of Hematology, 1982
- The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapyMedical and Pediatric Oncology, 1982
- Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimensBlood, 1979
- Remission induction in acute nonlymphocytic leukemia: Comparison of a seven‐day and ten‐day infusion of cytosine arabinoside in combination with adriamycinMedical and Pediatric Oncology, 1979
- Prognosis of Acute Myeloblastic Leukemia: Chromosomal CorrelationBlood, 1973
- LEUKÆMIC TRANSFORMATION OF ENGRAFTED HUMAN MARROW CELLS IN VIVOThe Lancet, 1971